Healthcare provider profile · identity verified

Enrique Robles, M.D.

Family Practice · DOWNEY, CA · NPI 1932155157

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	783	251
Levothyroxine Sodium	Levothyroxine Sodium	464	135
Amlodipine Besylate	Amlodipine Besylate	379	121
Metformin Hcl	Metformin Hcl	346	113
Losartan Potassium	Losartan Potassium	342	104
Lisinopril	Lisinopril	290	95
Pantoprazole Sodium	Pantoprazole Sodium	257	88
Tamsulosin Hcl	Tamsulosin Hcl	237	77
Azithromycin	Azithromycin	233	159
Furosemide	Furosemide	231	89
Omeprazole	Omeprazole	224	80
Simvastatin	Simvastatin	215	63
Alprazolam	Alprazolam	191	55
Hydrochlorothiazide	Hydrochlorothiazide	171	52
Lorazepam	Lorazepam	170	36
Fluticasone Propionate	Fluticasone Propionate	160	69
Metoprolol Succinate	Metoprolol Succinate	145	47
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	136	27
Glipizide	Glipizide	124	40
Escitalopram Oxalate	Escitalopram Oxalate	122	40
Benazepril Hcl	Benazepril Hcl	121	38
Finasteride	Finasteride	117	35
Gabapentin	Gabapentin	116	46
Albuterol Sulfate Hfa	Albuterol Sulfate	114	43
Diclofenac Sodium	Diclofenac Sodium	106	46
Ibuprofen	Ibuprofen	105	51
Atenolol	Atenolol	104	31
Tramadol Hcl	Tramadol Hcl	100	38
Alendronate Sodium	Alendronate Sodium	99	33
Metoprolol Tartrate	Metoprolol Tartrate	98	30
Eliquis	Apixaban	91	24
Carvedilol	Carvedilol	84	28
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	70	57
Trazodone Hcl	Trazodone Hcl	67	27
Lovastatin	Lovastatin	65	19
Ciprofloxacin Hcl	Ciprofloxacin Hcl	64	52
Potassium Chloride	Potassium Chloride	63	22
Meclizine Hcl	Meclizine Hcl	61	32
Ozempic	Semaglutide	61	11
Prednisone	Prednisone	61	35
Baclofen	Baclofen	58	29
Donepezil Hcl	Donepezil Hcl	58	20
Famotidine	Famotidine	55	21
Glimepiride	Glimepiride	55	19
Memantine Hcl	Memantine Hcl	55	16
Metformin Hcl Er	Metformin Hcl	55	21
Quetiapine Fumarate	Quetiapine Fumarate	55	16
Cephalexin	Cephalexin	54	34
Lactulose	Lactulose	53	28
Nifedipine Er	Nifedipine	53	17
Clopidogrel	Clopidogrel Bisulfate	51	17
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	51	13
Rosuvastatin Calcium	Rosuvastatin Calcium	51	17
Citalopram Hbr	Citalopram Hydrobromide	47	14
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	46	13
Montelukast Sodium	Montelukast Sodium	46	13
Hydralazine Hcl	Hydralazine Hcl	45	17
Temazepam	Temazepam	44	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	44	33
Pregabalin	Pregabalin	42	11
Levofloxacin	Levofloxacin	40	32
Sertraline Hcl	Sertraline Hcl	40	15
Allopurinol	Allopurinol	39	11
Paxlovid	Nirmatrelvir/Ritonavir	39	37
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	38	12
Clonazepam	Clonazepam	37	suppressed
Naproxen	Naproxen	36	12
Januvia	Sitagliptin Phosphate	35	suppressed
Duloxetine Hcl	Duloxetine Hcl	34	11
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	34	suppressed
Pravastatin Sodium	Pravastatin Sodium	34	12
Nystatin	Nystatin	33	15
Paroxetine Hcl	Paroxetine Hcl	31	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	31	11
Wixela Inhub	Fluticasone Propion/Salmeterol	31	11
Hydrocortisone	Hydrocortisone	30	16
Glipizide Er	Glipizide	29	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	28	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	26	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	26	suppressed
Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	25	suppressed
Ipratropium Bromide	Ipratropium Bromide	25	13
Humulin N	Insulin Nph Human Isophane	22	suppressed
Synthroid	Levothyroxine Sodium	22	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	21	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	21	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	21	18
Oxybutynin Chloride	Oxybutynin Chloride	21	suppressed
Acyclovir	Acyclovir	20	14
Eszopiclone	Eszopiclone	20	suppressed
Xarelto	Rivaroxaban	20	suppressed
Felodipine Er	Felodipine	19	suppressed
Fenofibrate	Fenofibrate	19	suppressed
Verapamil Er	Verapamil Hcl	18	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	17	suppressed
Irbesartan	Irbesartan	17	suppressed
Jardiance	Empagliflozin	17	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	17	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	16	suppressed
Clonidine Hcl	Clonidine Hcl	16	suppressed
Diclofenac Potassium	Diclofenac Potassium	16	suppressed
Digoxin	Digoxin	16	suppressed
Spironolactone	Spironolactone	16	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	16	12
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	15	suppressed
Breo Ellipta	Fluticasone/Vilanterol	15	suppressed
Meloxicam	Meloxicam	15	suppressed
Mirtazapine	Mirtazapine	15	suppressed
Ropinirole Hcl	Ropinirole Hcl	15	suppressed
Ketoconazole	Ketoconazole	14	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	13	suppressed
Propranolol Hcl	Propranolol Hcl	13	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	13	suppressed
Breyna	Budesonide/Formoterol Fumarate	12	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	12	suppressed
Ezetimibe	Ezetimibe	12	suppressed
Insulin Syringe	Syringe And Needle,insulin,1ml	12	suppressed
Linzess	Linaclotide	12	suppressed
Dextroamphetamine Sulfate Er	Dextroamphetamine Sulfate	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Mounjaro	Tirzepatide	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed
Oxycodone Hcl	Oxycodone Hcl	11	suppressed
Tizanidine Hcl	Tizanidine Hcl	11	suppressed
Valsartan	Valsartan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error